GLP-1 drugs directly activate powerful appetite-suppressing and metabolic receptors in the brain and gut, while berberine indirectly supports metabolic enzymes
Compounded products are not identical to brand products and are priced separately
While metformin remains the first-line treatment for T2D, GLP-1s may be used in combination with metformin for additional benefits
Additionally, one study measuring the effects of ashwagandha observed people taking the botanical for eight weeks
Sources New England Journal of Medicine: Once-Weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics: Semaglutide for the treatment of overweight and obesity: A review JAMA Network: Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity American Diabetes Association: Standards of Medical Care in Diabetes, 2025 Harvard Health Publishing: GLP-1 diabetes and weight-loss drug side effects: Ozempic face and more University of Illinois Chicago: What efficacy data are available on the use of tirzepatide for obesity
Over the past several years, scientists have begun exploring whether GLP-1 drugs might influence the brains structure itself
